Skip to main content

What your patients with gastroparesis need to know about Enterra Therapy

(0:01:17)

Diana McFarlane, PA-C, Gastroparesis Program Director and GI APP Lead at Virginia Mason Franciscan Health, and an Enterra user since 2012, shares answers to commonly asked questions from her patients with diabetic and idiopathic gastroparesis when asked about how Enterra Therapy could help with their nausea and vomiting symptoms.

Watch video

Diana McFarlane, PA-C

Gastroparesis Program Director and GI APP Lead
Virginia Mason Franciscan Health

IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?